1. Introduction & Mechanism of Action of Pyrukynd Pyrukynd is an oral targeted therapy containing mitapivat, prescribed specifically for the treatment of hemolytic anemia in adult patients suffering from pyruvate kinase deficiency. Its most notable clinical side effects include significant decreases in estrone and estradiol hormone levels in males, alongside moderate to severe musculoskeletal discomfort … Read more
1. Introduction to Hereditary Spherocytosis Hereditary spherocytosis is a genetic blood disorder characterized by a structural defect in the red blood cells. Instead of their normal, flexible, disc-like shape, the red blood cells in this condition become spherical and fragile. These abnormal cells are prone to premature destruction, leading to a specific type of blood … Read more
1. Introduction Hereditary hemolytic anemia encompasses a diverse group of complex genetic blood disorders defined by the premature destruction of red blood cells. Under healthy physiological conditions, a red blood cell circulates through the extensive vascular network of the body for roughly one hundred and twenty days, delivering vital oxygen to tissues. In these inherited … Read more
1. Introduction Hemolytic anemia is a complex hematological condition defined by the premature destruction of red blood cells. Under normal physiological conditions, a red blood cell circulates through the vast vascular network of the body for roughly one hundred and twenty days before undergoing natural breakdown and recycling. In hemolytic disorders, this lifespan is drastically … Read more